NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference
NuVasive, a leader in spine technology, announced that CEO Chris Barry will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 12:00 p.m. PT. The presentation will focus on minimally invasive surgical solutions and innovations in spine technology. A live webcast will be accessible on the Company's Investor Relations page, with a replay available for 30 days. With over $1 billion in net sales and a presence in more than 50 countries, NuVasive is committed to advancing surgical care and improving patient outcomes.
- None.
- None.
SAN DIEGO, Dec. 28, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will virtually present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 12:00 p.m. PT / 3:00 p.m. ET.
A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. After the live webcast, a replay of the presentation will remain available on the website for 30 days.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-in-40th-annual-jp-morgan-healthcare-conference-301450934.html
SOURCE NuVasive, Inc.
FAQ
When will NuVasive CEO Chris Barry present at the J.P. Morgan Healthcare Conference?
How can I watch the NuVasive presentation at the Healthcare Conference?
What is the focus of NuVasive's presentation at the J.P. Morgan Conference?
How long will the NuVasive presentation replay be available?
What is NuVasive's position in the spine technology market?
